COVID-19: Gastrointestinal Manifestations and Complications

The virus responsible for the COVID-19 pandemic is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the genus Betacoronavirus. This genus also includes the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus...

Full description

Saved in:
Bibliographic Details
Main Authors: Angel Yun-Kuan Thye, Priyia Pusparajah, Loh Teng-Hern Tan, Jodi Woan-Fei Law, Vengadesh Letchumanan, Learn-Han Lee
Format: Article
Language:English
Published: HH Publisher 2021-11-01
Series:Progress in Microbes and Molecular Biology
Online Access:https://journals.hh-publisher.com/index.php/pmmb/article/view/513
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832541393150541824
author Angel Yun-Kuan Thye
Priyia Pusparajah
Loh Teng-Hern Tan
Jodi Woan-Fei Law
Vengadesh Letchumanan
Learn-Han Lee
author_facet Angel Yun-Kuan Thye
Priyia Pusparajah
Loh Teng-Hern Tan
Jodi Woan-Fei Law
Vengadesh Letchumanan
Learn-Han Lee
author_sort Angel Yun-Kuan Thye
collection DOAJ
description The virus responsible for the COVID-19 pandemic is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the genus Betacoronavirus. This genus also includes the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). The common symptoms of COVID-19 infection are fever and respiratory symptoms, but it can also involve the gastrointestinal tract (GIT), resulting in manifestations such as diarrhea, nausea and/or vomiting and abdominal pain. The emergence of COVID-19 led to public health emphasis on droplet transmission and precautions of contact with respiratory secretions. However, mounting evidence demonstrates detection of SARS-CoV-2 RNA in stool samples of COVID-19 patients. It has also been demonstrated that the host receptor angiotensin-converting-enzyme-2 (ACE-2) is highly expressed not just in respiratory cells but also in gastrointestinal sites involving the glandular cells of gastric, duodenal, and rectal epithelium. This suggests that SARS-CoV-2 can infect the digestive system, serving as another route of transmission. This review aims to study the prevalence of some of the gastrointestinal manifestations following COVID-19 infection and findings of positive SARS-CoV-2 RNA in stool specimens while making parallels to the severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) infection. We will also discuss the possible pathophysiology of COVID-19 related gastrointestinal involvement.
format Article
id doaj-art-2f19320af06440b7a86afc3f20473205
institution Kabale University
issn 2637-1049
language English
publishDate 2021-11-01
publisher HH Publisher
record_format Article
series Progress in Microbes and Molecular Biology
spelling doaj-art-2f19320af06440b7a86afc3f204732052025-02-04T08:40:11ZengHH PublisherProgress in Microbes and Molecular Biology2637-10492021-11-014110.36877/pmmb.a0000247COVID-19: Gastrointestinal Manifestations and ComplicationsAngel Yun-Kuan ThyePriyia PusparajahLoh Teng-Hern TanJodi Woan-Fei LawVengadesh LetchumananLearn-Han LeeThe virus responsible for the COVID-19 pandemic is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which belongs to the genus Betacoronavirus. This genus also includes the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). The common symptoms of COVID-19 infection are fever and respiratory symptoms, but it can also involve the gastrointestinal tract (GIT), resulting in manifestations such as diarrhea, nausea and/or vomiting and abdominal pain. The emergence of COVID-19 led to public health emphasis on droplet transmission and precautions of contact with respiratory secretions. However, mounting evidence demonstrates detection of SARS-CoV-2 RNA in stool samples of COVID-19 patients. It has also been demonstrated that the host receptor angiotensin-converting-enzyme-2 (ACE-2) is highly expressed not just in respiratory cells but also in gastrointestinal sites involving the glandular cells of gastric, duodenal, and rectal epithelium. This suggests that SARS-CoV-2 can infect the digestive system, serving as another route of transmission. This review aims to study the prevalence of some of the gastrointestinal manifestations following COVID-19 infection and findings of positive SARS-CoV-2 RNA in stool specimens while making parallels to the severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) infection. We will also discuss the possible pathophysiology of COVID-19 related gastrointestinal involvement. https://journals.hh-publisher.com/index.php/pmmb/article/view/513
spellingShingle Angel Yun-Kuan Thye
Priyia Pusparajah
Loh Teng-Hern Tan
Jodi Woan-Fei Law
Vengadesh Letchumanan
Learn-Han Lee
COVID-19: Gastrointestinal Manifestations and Complications
Progress in Microbes and Molecular Biology
title COVID-19: Gastrointestinal Manifestations and Complications
title_full COVID-19: Gastrointestinal Manifestations and Complications
title_fullStr COVID-19: Gastrointestinal Manifestations and Complications
title_full_unstemmed COVID-19: Gastrointestinal Manifestations and Complications
title_short COVID-19: Gastrointestinal Manifestations and Complications
title_sort covid 19 gastrointestinal manifestations and complications
url https://journals.hh-publisher.com/index.php/pmmb/article/view/513
work_keys_str_mv AT angelyunkuanthye covid19gastrointestinalmanifestationsandcomplications
AT priyiapusparajah covid19gastrointestinalmanifestationsandcomplications
AT lohtengherntan covid19gastrointestinalmanifestationsandcomplications
AT jodiwoanfeilaw covid19gastrointestinalmanifestationsandcomplications
AT vengadeshletchumanan covid19gastrointestinalmanifestationsandcomplications
AT learnhanlee covid19gastrointestinalmanifestationsandcomplications